Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of Flibanserin in the treatment of obesity

Use of Flibanserin in the treatment of obesity

US Patent 10874668 · Granted Dec 29, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the additive manufacturing of at least one component of defined compo2025
4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament2021
4-pyridinylmethyl-morpholine derivatives and the use thereof as medicament2021
4-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament2021
Imidazopyridine derivatives and the use thereof as medicament2020
Use of flibanserin in the treatment of obesity2019
Use of flibanserin in the treatment of obesity2019
Flibanserin for the treatment of urinary incontinence and related diseases2018
Flibanserin for the treatment of urinary incontinence and related diseases2017
Use of flibanserin in the treatment of obesity2017
Use of flibanserin in the treatment of obesity2017
6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmac2016